CTOR
Citius Oncology, Inc.
1.10$
+4.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +2.5% | +2.2% | +68.7% | +7.2% | +1.1% | +0.3% | +10.1% | +8.9% | -8.4% | +11.3% | |
| – | +0.0% | +15.2% | +12.4% | +9.6% | +55.7% | +5.6% | +1.5% | +50.4% | +34.9% | -20.8% | +45.1% | |
| – | +23.5% | +1.8% | -99.2% | -57.1% | +0.0% | +0.0% | +0.0% | +3,504,282.1% | +85.9% | -63.9% | +529.2% | |
| – | +23.5% | +1.8% | -99.2% | -57.1% | +0.0% | +0.0% | +0.0% | +3,504,282.1% | +85.9% | -63.9% | +529.2% | |
| – | – | – | – | – | – | – | – | – | – | -73.4% | -36.4% | |
| – | – | – | – | – | +73.9% | +6.7% | +12.2% | +29.5% | +1.6% | +0.1% | -0.1% | |
| – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | -0.8% | -2.4% | -2.4% | |
| – | +12.7% | +16.2% | +13.5% | +15.9% | +28.7% | +13.4% | +6.3% | -5.5% | -8.1% | +26.9% | +9.6% | |
| – | +12.7% | +16.5% | +13.7% | +4.2% | +32.7% | +14.6% | +6.5% | -6.6% | -9.7% | +31.5% | 0.0% | |
| – | – | – | +13.2% | – | – | – | – | – | – | – | – | |
| – | -84.1% | +145.8% | – | – | +58.3% | +30.7% | +12.9% | +52.7% | -21.1% | -15.0% | -17.6% | |
| – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +168.7% | |
| – | -11.0% | -12.7% | -14.2% | +170.9% | -10.5% | -13.7% | -9.1% | +38.5% | +30.2% | -39.6% | +14.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.1% | -25.6% | +0.0% | +7.5% | +0.0% | +0.0% | +0.0% | +13.1% | +8.1% | +14.4% | +7.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.